INTEGRA LS (BENELUX) (0470.175.826): annual accounts and directors

CHECKED

Create an account

Companies

Search companies
Addresses
Company groups
Nearby
Service voucher comparison

People and firms

Directors
Bankruptcy trustees
Notaries

Events

Events: Overview
All events

Company changes

Incorporations
Director changes
Name changes
Registered office moves
Mergers and takeovers

Financial publications

Annual accounts filed
Capital changes
Auditor changes

Legal status & closure

Bankruptcies
Judicial reorganisations
Dissolutions and liquidations
Ex-officio strike-offs
Interim measures

Tools

Tools: Overview

Investigate

Analysis workbench
Compare companies
Sector benchmark
Employer check
Network investigator
Company wealth map
Lookalike companies
Company as of a date
Permit applications

Assess companies

Credit check
Supplier due diligence
AML client file
Creditor guide
Contractor check
Self-check
Public procurement exclusion grounds
Service voucher comparison

Market and sector

Sector figures
Municipality map
Subsidies
Market analysis
Trends
Rankings
Survival tables
Public contracts

Invoices and lists

Invoice check
Peppol check
Process a list

Starting out

Name check
Local market research
Starter mirror
Financial plan

NL FR EN

Nederlands Français English

My Checked

Sign in
Create an account

Home / Search companies / Wholesale of pharmaceutical and medical goods / INTEGRA LS (BENELUX)

INTEGRA LS (BENELUX)

Ghent ·KBO/BCE: BE 0470.175.826

Loading dossier…

Checked · Insight, alerts and connections for every Belgian company, from official sources.

Based on official Belgian registers and filed annual accounts.

NL FR EN

Discover

All tools Sector figures Rankings Municipality map All events Company groups Trends Survival tables

Checked

About Checked Contact Pricing

Help and guides

Frequently asked questions Knowledge base

Integrations

API AI assistants Excel and Google Sheets Company badge

Legal

We would like to set cookies. That happens only with your consent. What we measure

Help us improve Checked

If something looks wrong or is missing, please tell us.

Your message Email (optional, only to reply)

Group	Expected	Actual
1	0.2%	0.2%
2	0.3%	0.5%
3	0.5%	0.6%
4	0.7%	0.8%
5	0.9%	0.9%
6	1.3%	1.5%
7	1.6%	1.8%
8	1.8%	1.8%
9	2.9%	3.1%
10	5.6%	6.1%

Company
INTEGRA LS (BENELUX) Ghent	€7.1m	5.4%	87.0%	18.1
ANTON PAAR BELGIUM Ghent	€8.3m	2.6%	66.3%	28.2
ARSEUS LAB Waregem	€10.2m	3.4%	50.9%	20.7
EISAI Leuven	€7.6m	4.0%	65.1%	12.6
Fedegari Europe Anderlecht	€5.9m	23.1%	83.6%	15.1
CORIS BIOCONCEPT Gembloux	€5.5m	-7.2%	82.1%	31.2
ixX pharma Antwerp	€11.6m	18.9%	61.4%	26.3

INTEGRA LS (BENELUX)

Lifetime

Key points

Staff

Payment terms

Filings

Checked score

Financial strength

Score breakdown

Comparable companies, two years later

Credit verdict

Signals

Board and ownership

Recent changes

Comparable companies

Official details

Annual accounts 2025

Insights on INTEGRA LS (BENELUX)

Key facts about INTEGRA LS (BENELUX)

Next steps